MedPAC > Our Work > Drugs, Devices, and Tests > MedPAC comment on CMS’s proposed rule entitled: Medicare Program; Revisions to the Medicare Advantage and Prescription Drug Benefit Programs
MedPAC comment on CMS’s proposed rule entitled: Medicare Program; Revisions to the Medicare Advantage and Prescription Drug Benefit Programs